Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 5;77(5):1002-1008.
doi: 10.1093/gerona/glab155.

Dose-Response Relationships Between Polypharmacy and All-Cause and Cause-Specific Mortality Among Older People

Yun-Ting Huang  1 , Andrew Steptoe  2 , Li Wei  3 , Paola Zaninotto  1
Affiliations

Dose-Response Relationships Between Polypharmacy and All-Cause and Cause-Specific Mortality Among Older People

Yun-Ting Huang et al. J Gerontol A Biol Sci Med Sci. .

Abstract

Background: Although medicines are prescribed based on clinical guidelines and expected to benefit patients, both positive and negative health outcomes have been reported associated with polypharmacy. Mortality is the main outcome, and information on cause-specific mortality is scarce. Hence, we investigated the association between different levels of polypharmacy and all-cause and cause-specific mortality among older adults.

Method: The English Longitudinal Study of Ageing is a nationally representative study of people aged 50+. From 2012/2013, 6 295 individuals were followed up to April 2018 for all-cause and cause-specific mortality. Polypharmacy was defined as taking 5-9 long-term medications daily and heightened polypharmacy as 10+ medications. Cox proportional hazards regression and competing-risks regression were used to examine associations between polypharmacy and all-cause and cause-specific mortality, respectively.

Results: Over a 6-year follow-up period, both polypharmacy (19.3%) and heightened polypharmacy (2.4%) were related to all-cause mortality, with hazard ratios of 1.51 (95% CI: 1.05-2.16) and 2.29 (95% CI: 1.40-3.75) respectively, compared with no medications, independently of demographic factors, serious illnesses and long-term conditions, cognitive function, and depression. Polypharmacy and heightened polypharmacy also showed 2.45 (95% CI: 1.13-5.29) and 3.67 (95% CI: 1.43-9.46) times higher risk of cardiovascular disease deaths, respectively. Cancer mortality was only related to heightened polypharmacy.

Conclusion: Structured medication reviews are currently advised for heightened polypharmacy, but our results suggest that greater attention to polypharmacy in general for older people may reduce adverse effects and improve older adults' health.

Keywords: All-cause mortality; Cardiovascular disease mortality; Epidemiology; Heightened polypharmacy; Polypharmacy.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Associations between the number of concurrent drugs and mortality, England 2012–2018. CVD = cardiovascular disease; HR = hazard ratio.
Figure 2.
Figure 2.
Polypharmacy performs differently in all-cause, CVD, and cancer mortality, England 2012–2018. CIF = cumulative incidence function; CVD = cardiovascular disease.
See this image and copyright information in PMC

References

    1. World Health Organization. Multimorbidity. Technical Series on Safer Primary Care. 2016. https://apps.who.int/iris/handle/10665/252275. Accessed June 4, 2020.
    1. World Health Organization. Medication Safety in Polypharmacy. 2019. https://apps.who.int/iris/rest/bitstreams/1235792/. Accessed July 24, 2020.
    1. Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230–230. doi:10.1186/s12877-017-0621-2 - DOI - PMC - PubMed
    1. National Institute for Health and Care Excellence (NICE). Multimorbidity and Polypharmacy. 2019. https://www.nice.org.uk/advice/ktt18/chapter/Evidence-context. Accessed July 24, 2020.
    1. NHS England and NHS Improvement. Network Contract Direct Enhanced Service: Draft Outline Service Specifications. 2019. https://www.engage.england.nhs.uk/survey/primary-care-networks-service-s.... Accessed July 24, 2020.

Publication types